A2 Biotherapeutics Stock

A2 Biotherapeutics develops novel medicines for serious illness.

Sign up today and learn more about A2 Biotherapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About A2 Biotherapeutics Stock

A2 Biotherapeutics is an early-stage biotechnology company located in Southern California that develops novel medicines for serious illnesses. We utilize an advanced targeting technology platform to increase the effectiveness of the body’s natural immune defenses.

Funding History

November 2019$57.0M
October 2020$71.5M


Sr Director Technology

Han Xu

Independent Director

Madhavan Balachandran

Vice President, Head of Technical Operations

Michelle Kreke

Vice President Operations

David Lucas

Senior Director Drug Discovery

Agi Hamburger

President and CSO

Alexander Kamb

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: